Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents. Beyer, L., P., Wohlgemuth, W., A., Uller, W., Pregler, B., Goessmann, H., Niessen, C., Haimerl, M., Stroszczynski, C., & Müller-Wille, R. European journal of radiology, 84(10):1964-9, Elsevier Ireland Ltd, 10, 2015.
Paper
Website abstract bibtex PURPOSE To evaluate the technical and clinical success of percutaneous superior mesenteric vein (SMV) stenting in symptomatic patients using self-expanding nitinol stents. METHODS We retrospectively analyzed the technical and clinical success of percutaneous SMV stenting of 6 symptomatic patients (3 men, mean age 67 years, range 48-81 years). Stenosis of the SMV was caused by postoperative stricture (n=3), pancreas carcinoma (n=1) and pancreatitis (n=2). As a result of the stenosis, 3 patients had symptomatic ascites, 2 patients showed signs of mesenteric ischemia and 1 patient had recurrent gastrointestinal bleeding. Stenting was performed by a percutaneous transhepatic approach using self-expanding nitinol stents. RESULTS Stenting of the SMV was technically and clinically successful in all patients. No peri-interventional complications occurred. The stent diameters ranged from 6 to 14 mm. During the mean follow-up of 6 months (range, 2-10 months) 1 patient presented early stent occlusion 2 weeks after placement. CONCLUSION Stenting of a symptomatic SMV stenosis using self-expanding nitinol stents is feasible and clinically effective.
@article{
title = {Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.},
type = {article},
year = {2015},
identifiers = {[object Object]},
keywords = {Abdomen/GI,Angioplasty,Mesentery,Percutaneous,Stents},
pages = {1964-9},
volume = {84},
websites = {http://linkinghub.elsevier.com/retrieve/pii/S0720048X15300206,http://www.ncbi.nlm.nih.gov/pubmed/26137903},
month = {10},
publisher = {Elsevier Ireland Ltd},
id = {f6ca2f98-9178-312e-925b-e8efa88c1891},
created = {2017-10-23T15:16:55.608Z},
accessed = {2017-04-20},
file_attached = {true},
profile_id = {dc035ccf-3dbf-39ac-9451-b120a251b0ff},
last_modified = {2017-10-23T15:17:06.322Z},
read = {false},
starred = {false},
authored = {true},
confirmed = {true},
hidden = {false},
citation_key = {Beyer2015},
notes = {<b>From Duplicate 1 (<i>Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.</i> - Beyer, L P; Wohlgemuth, W A; Uller, W.; Pregler, B.; Goessmann, H.; Niessen, C.; Haimerl, M.; Stroszczynski, C.; Müller-Wille, R.)<br/></b><br/><b>From Duplicate 1 (<i>Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.</i> - Beyer, L P; Wohlgemuth, W A; Uller, W.; Pregler, B.; Goessmann, H.; Niessen, C.; Haimerl, M.; Stroszczynski, C.; Müller-Wille, R.)<br/></b><br/><b>Impact Factor<br/></b><i>2015 </i><b>2.593<br/></b><i>5 year </i><b>2.518</b><i><br/></i>},
private_publication = {false},
abstract = {PURPOSE To evaluate the technical and clinical success of percutaneous superior mesenteric vein (SMV) stenting in symptomatic patients using self-expanding nitinol stents. METHODS We retrospectively analyzed the technical and clinical success of percutaneous SMV stenting of 6 symptomatic patients (3 men, mean age 67 years, range 48-81 years). Stenosis of the SMV was caused by postoperative stricture (n=3), pancreas carcinoma (n=1) and pancreatitis (n=2). As a result of the stenosis, 3 patients had symptomatic ascites, 2 patients showed signs of mesenteric ischemia and 1 patient had recurrent gastrointestinal bleeding. Stenting was performed by a percutaneous transhepatic approach using self-expanding nitinol stents. RESULTS Stenting of the SMV was technically and clinically successful in all patients. No peri-interventional complications occurred. The stent diameters ranged from 6 to 14 mm. During the mean follow-up of 6 months (range, 2-10 months) 1 patient presented early stent occlusion 2 weeks after placement. CONCLUSION Stenting of a symptomatic SMV stenosis using self-expanding nitinol stents is feasible and clinically effective.},
bibtype = {article},
author = {Beyer, L.P. P and Wohlgemuth, W.A. A and Uller, W. and Pregler, B. and Goessmann, H. and Niessen, C. and Haimerl, M. and Stroszczynski, C. and Müller-Wille, R.},
journal = {European journal of radiology},
number = {10}
}
Downloads: 0
{"_id":"ZfJNL5wX69YmpZDtY","bibbaseid":"beyer-wohlgemuth-uller-pregler-goessmann-niessen-haimerl-stroszczynski-etal-percutaneoustreatmentofsymptomaticsuperiormesentericveinstenosisusingselfexpandingnitinolstents-2015","downloads":0,"creationDate":"2017-12-22T21:31:34.458Z","title":"Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.","author_short":["Beyer, L., P.","Wohlgemuth, W., A.","Uller, W.","Pregler, B.","Goessmann, H.","Niessen, C.","Haimerl, M.","Stroszczynski, C.","Müller-Wille, R."],"year":2015,"bibtype":"article","biburl":null,"bibdata":{"title":"Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.","type":"article","year":"2015","identifiers":"[object Object]","keywords":"Abdomen/GI,Angioplasty,Mesentery,Percutaneous,Stents","pages":"1964-9","volume":"84","websites":"http://linkinghub.elsevier.com/retrieve/pii/S0720048X15300206,http://www.ncbi.nlm.nih.gov/pubmed/26137903","month":"10","publisher":"Elsevier Ireland Ltd","id":"f6ca2f98-9178-312e-925b-e8efa88c1891","created":"2017-10-23T15:16:55.608Z","accessed":"2017-04-20","file_attached":"true","profile_id":"dc035ccf-3dbf-39ac-9451-b120a251b0ff","last_modified":"2017-10-23T15:17:06.322Z","read":false,"starred":false,"authored":"true","confirmed":"true","hidden":false,"citation_key":"Beyer2015","notes":"<b>From Duplicate 1 (<i>Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.</i> - Beyer, L P; Wohlgemuth, W A; Uller, W.; Pregler, B.; Goessmann, H.; Niessen, C.; Haimerl, M.; Stroszczynski, C.; Müller-Wille, R.)<br/></b><br/><b>From Duplicate 1 (<i>Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.</i> - Beyer, L P; Wohlgemuth, W A; Uller, W.; Pregler, B.; Goessmann, H.; Niessen, C.; Haimerl, M.; Stroszczynski, C.; Müller-Wille, R.)<br/></b><br/><b>Impact Factor<br/></b><i>2015 </i><b>2.593<br/></b><i>5 year </i><b>2.518</b><i><br/></i>","private_publication":false,"abstract":"PURPOSE To evaluate the technical and clinical success of percutaneous superior mesenteric vein (SMV) stenting in symptomatic patients using self-expanding nitinol stents. METHODS We retrospectively analyzed the technical and clinical success of percutaneous SMV stenting of 6 symptomatic patients (3 men, mean age 67 years, range 48-81 years). Stenosis of the SMV was caused by postoperative stricture (n=3), pancreas carcinoma (n=1) and pancreatitis (n=2). As a result of the stenosis, 3 patients had symptomatic ascites, 2 patients showed signs of mesenteric ischemia and 1 patient had recurrent gastrointestinal bleeding. Stenting was performed by a percutaneous transhepatic approach using self-expanding nitinol stents. RESULTS Stenting of the SMV was technically and clinically successful in all patients. No peri-interventional complications occurred. The stent diameters ranged from 6 to 14 mm. During the mean follow-up of 6 months (range, 2-10 months) 1 patient presented early stent occlusion 2 weeks after placement. CONCLUSION Stenting of a symptomatic SMV stenosis using self-expanding nitinol stents is feasible and clinically effective.","bibtype":"article","author":"Beyer, L.P. P and Wohlgemuth, W.A. A and Uller, W. and Pregler, B. and Goessmann, H. and Niessen, C. and Haimerl, M. and Stroszczynski, C. and Müller-Wille, R.","journal":"European journal of radiology","number":"10","bibtex":"@article{\n title = {Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.},\n type = {article},\n year = {2015},\n identifiers = {[object Object]},\n keywords = {Abdomen/GI,Angioplasty,Mesentery,Percutaneous,Stents},\n pages = {1964-9},\n volume = {84},\n websites = {http://linkinghub.elsevier.com/retrieve/pii/S0720048X15300206,http://www.ncbi.nlm.nih.gov/pubmed/26137903},\n month = {10},\n publisher = {Elsevier Ireland Ltd},\n id = {f6ca2f98-9178-312e-925b-e8efa88c1891},\n created = {2017-10-23T15:16:55.608Z},\n accessed = {2017-04-20},\n file_attached = {true},\n profile_id = {dc035ccf-3dbf-39ac-9451-b120a251b0ff},\n last_modified = {2017-10-23T15:17:06.322Z},\n read = {false},\n starred = {false},\n authored = {true},\n confirmed = {true},\n hidden = {false},\n citation_key = {Beyer2015},\n notes = {<b>From Duplicate 1 (<i>Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.</i> - Beyer, L P; Wohlgemuth, W A; Uller, W.; Pregler, B.; Goessmann, H.; Niessen, C.; Haimerl, M.; Stroszczynski, C.; Müller-Wille, R.)<br/></b><br/><b>From Duplicate 1 (<i>Percutaneous treatment of symptomatic superior mesenteric vein stenosis using self-expanding nitinol stents.</i> - Beyer, L P; Wohlgemuth, W A; Uller, W.; Pregler, B.; Goessmann, H.; Niessen, C.; Haimerl, M.; Stroszczynski, C.; Müller-Wille, R.)<br/></b><br/><b>Impact Factor<br/></b><i>2015 </i><b>2.593<br/></b><i>5 year </i><b>2.518</b><i><br/></i>},\n private_publication = {false},\n abstract = {PURPOSE To evaluate the technical and clinical success of percutaneous superior mesenteric vein (SMV) stenting in symptomatic patients using self-expanding nitinol stents. METHODS We retrospectively analyzed the technical and clinical success of percutaneous SMV stenting of 6 symptomatic patients (3 men, mean age 67 years, range 48-81 years). Stenosis of the SMV was caused by postoperative stricture (n=3), pancreas carcinoma (n=1) and pancreatitis (n=2). As a result of the stenosis, 3 patients had symptomatic ascites, 2 patients showed signs of mesenteric ischemia and 1 patient had recurrent gastrointestinal bleeding. Stenting was performed by a percutaneous transhepatic approach using self-expanding nitinol stents. RESULTS Stenting of the SMV was technically and clinically successful in all patients. No peri-interventional complications occurred. The stent diameters ranged from 6 to 14 mm. During the mean follow-up of 6 months (range, 2-10 months) 1 patient presented early stent occlusion 2 weeks after placement. CONCLUSION Stenting of a symptomatic SMV stenosis using self-expanding nitinol stents is feasible and clinically effective.},\n bibtype = {article},\n author = {Beyer, L.P. P and Wohlgemuth, W.A. A and Uller, W. and Pregler, B. and Goessmann, H. and Niessen, C. and Haimerl, M. and Stroszczynski, C. and Müller-Wille, R.},\n journal = {European journal of radiology},\n number = {10}\n}","author_short":["Beyer, L., P.","Wohlgemuth, W., A.","Uller, W.","Pregler, B.","Goessmann, H.","Niessen, C.","Haimerl, M.","Stroszczynski, C.","Müller-Wille, R."],"urls":{"Paper":"http://bibbase.org/service/mendeley/dc035ccf-3dbf-39ac-9451-b120a251b0ff/file/5091ecb8-91a7-6db9-3c2b-c80167898eb2/2015-Percutaneous_treatment_of_symptomatic_superior_mesenteric_vein_stenosis_using_self-expanding_nitinol_stents..pdf.pdf","Website":"http://linkinghub.elsevier.com/retrieve/pii/S0720048X15300206,http://www.ncbi.nlm.nih.gov/pubmed/26137903"},"bibbaseid":"beyer-wohlgemuth-uller-pregler-goessmann-niessen-haimerl-stroszczynski-etal-percutaneoustreatmentofsymptomaticsuperiormesentericveinstenosisusingselfexpandingnitinolstents-2015","role":"author","keyword":["Abdomen/GI","Angioplasty","Mesentery","Percutaneous","Stents"],"downloads":0},"search_terms":["percutaneous","treatment","symptomatic","superior","mesenteric","vein","stenosis","using","self","expanding","nitinol","stents","beyer","wohlgemuth","uller","pregler","goessmann","niessen","haimerl","stroszczynski","müller-wille"],"keywords":["abdomen/gi","angioplasty","mesentery","percutaneous","stents"],"authorIDs":[]}